Galapagos



Ebit Cambiamento Data
argenx SE USD 14.19M 28.62M 2024-09
AstraZeneca USD 4.2B 119M 2024-12
Biogen USD 644.1M 100.9M 2024-12
Genmab DKK 2.16B 58M 2024-12
Gilead Sciences USD 3.11B 144M 2024-12
GlaxoSmithKline GBP 1.43B 1.33B 2024-12
GRIFOLS EUR 269.49M 73.1M 2024-06
Hikma Pharmaceutical USD 402M 96M 2024-06
Incyte USD 376.26M 121.03M 2024-12
Merck EUR 1.1B 305M 2024-09
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 4.86B 286M 2024-12
Roche Holding CHF 11.29B 2.68B 2024-06
Sanofi EUR 2.08B 1.69B 2024-12
UCB EUR 334M 163M 2024-06
Vertex Pharmaceuticals USD 1.2B 108.8M 2024-12



Galapagos - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.